YourChoice Therapeutics
PrivateLast Round
Grant
Mar 27, 2024
Est. Valuation
$2.14M
Total Funding Raised
$15.65M
Company Overview
YourChoice Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in March 2024.
YourChoice Therapeutics is a clinical-stage biopharmaceutical company that develops non-hormonal, oral contraceptive products for men and women.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YourChoice Therapeutics Comparables
Compare YourChoice Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuapoch, Inc. | 83% | |
| Next Life Sciences | 82% | |
| Contraline | 68% |
For institutional investors. Book with your work email.
YourChoice Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 27, 2024 | ||||
| Series A | Jul 1, 2022 | ||||
| Accelerator | Mar 14, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
YourChoice Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Male Contraceptive Initiative | Series A, Grant |
| Refactor Capital | Series A |
| Future Ventures | Series A |
| Portfolia | Series A |
| Y Combinator | Accelerator |
| RH Capital | Series A |
| North South Ventures | Series A |
For institutional investors. Book with your work email.
YourChoice Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about YourChoice Therapeutics's valuation, stock price, and market status.
Is YourChoice Therapeutics a public or private company?
YourChoice Therapeutics is a private company.
What is the current stock price of YourChoice Therapeutics?
YourChoice Therapeutics is a private company, so its shares have no public market price. Caplight tracks YourChoice Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is YourChoice Therapeutics worth (valuation)?
YourChoice Therapeutics's valuation is estimated at $2.1M based on funding round data.
Can I buy YourChoice Therapeutics stock?
YourChoice Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was YourChoice Therapeutics's last funding round?
YourChoice Therapeutics's most recent funding round was Grant on March 27, 2024.
Who are the main investors in YourChoice Therapeutics?
Key investors in YourChoice Therapeutics include Male Contraceptive Initiative, Future Ventures.
Will YourChoice Therapeutics IPO soon?
No public IPO plans have been announced for YourChoice Therapeutics.
How can I track YourChoice Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in YourChoice Therapeutics's shares on secondary markets.